Protagenic Therapeutics I... (PTIXW)
0.00
-0.01 (-100.00%)
At close: Apr 17, 2025, 9:54 AM
-100.00% (1D)
| Bid | n/a |
| Market Cap | 33.87K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 200 |
| Avg. Volume (20D) | 16,595.522 |
| Open | 0.00 |
| Previous Close | 0.01 |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 0.00 |
| Beta | 0.35 |
About PTIXW
Protagenic Therapeutics, Inc., a pre-clinical biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114 is a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company was founded in 2016 and is based in New York, New York....
Industry Biotechnology
Sector Healthcare
IPO Date Apr 27, 2021
Employees 1
Stock Exchange NASDAQ
Ticker Symbol PTIXW
Website http://www.protagenic.com